Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are still more hikes to come.

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

About 53 million Americans were enrolled in a Medicare prescription drug plan in 2024 ... The drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara ...

There were more than 56 million Medicare Part D participants in the prescription drug program during 2024 ... variations of Fiasp; Januvia, Jardiance; Imbruvica; Stelara; Xarelto; Those lower ...